EditorialBMC Headquarters Illuminated In Purple Colour To Create Awareness On The Occasion Of World Alzheimer Day, Mumbai, Maharashtra, India - 21 Sep 2022
EditorialA Cassava Sciences nameplate on the exterior of an office building in Austin, Texas, April 18, 2022. (Ilana Panich-Linsman/The New York Times)
EditorialPeople in favor of wider access to the Alzheimer’s drug Aduhelm rally outside the Department of Health and Human Services in Washington on March 15, 2022. (Kenny Holston/The New York Times)
EditorialDr. Daniel Gibbs, a retired neurologist with early-stage Alzheimer’s, says he agrees with Medicare’s proposed restrictions on Aduhelm. (Amanda Lucier/The New York Times)
EditorialDr. John Q. Trojanowski in his lab at the University of Pennsylvania in Philadelphia, June 10, 2010. (Sabina Louise Pierce/The New York Times)
EditorialDr. Janet Woodcock, then the director of drug evaluation and research at the Food and Drug Administration, in Silver Spring, Md., May 3, 2013. (Drew Angerer/The New York Times)